We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+14.45%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.83B
AUM Growth
-$23.2M
Cap. Flow
-$201M
Cap. Flow %
-10.94%
Top 10 Hldgs %
24.61%
Holding
261
New
14
Increased
25
Reduced
199
Closed
13

Top Buys

Rank Stock Value
1
SRAD icon
Sportradar
SRAD
+$23.7M
2
FOUR icon
Shift4
FOUR
+$22.6M
3
PRGS icon
Progress Software
PRGS
+$9.32M
4
QDEL icon
QuidelOrtho
QDEL
+$7.08M
5
VRDN icon
Viridian Therapeutics
VRDN
+$6.06M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$58.7M
2
WNS
WNS Holdings
WNS
+$46.2M
3
TKO icon
TKO Group
TKO
+$23.8M
4
WLDN icon
Willdan Group
WLDN
+$8.81M
5
EEFT icon
Euronet Worldwide
EEFT
+$7.12M

Sector Composition

Rank Sector Weight
1 Healthcare 32.04%
2 Technology 28.06%
3 Industrials 18.08%
4 Consumer Discretionary 6.84%
5 Communication Services 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARLO icon
1
Arlo Technologies
ARLO
$1.51B
$58.9M 3.21%
3,475,781
-376,446
-10% -$6.4M
ACIW icon
2
ACI Worldwide
ACIW
$5.88B
$52.6M 2.87%
996,565
+96,130
+11% +$4.54M
LGND icon
3
Ligand Pharmaceuticals
LGND
$5.96B
$52.2M 2.84%
294,490
-42,858
-13% -$6.37M
MEDP icon
4
Medpace
MEDP
$16.5B
$47M 2.56%
91,409
-11,045
-11% -$4.82M
LRN icon
5
Stride
LRN
$3.83B
$45.5M 2.48%
305,353
-27,670
-8% -$4.06M
FOUR icon
6
Shift4
FOUR
$3.96B
$45.2M 2.47%
584,231
+243,161
+71% +$22.6M
FN icon
7
Fabrinet
FN
$16.9B
$40.5M 2.21%
110,950
-11,238
-9% -$3.7M
DFIN icon
8
Donnelley Financial Solutions
DFIN
$1.26B
$39M 2.13%
759,068
-75,527
-9% -$4.31M
WIX icon
9
WIX.com
WIX
$2.36B
$35.9M 1.96%
201,986
+24,599
+14% +$3.7M
AWI icon
10
Armstrong World Industries
AWI
$7.05B
$34.6M 1.89%
176,662
-16,250
-8% -$3.02M
YOU icon
11
Clear Secure
YOU
$5.36B
$32.1M 1.75%
962,250
-81,590
-8% -$2.7M
PBH icon
12
Prestige Consumer Healthcare
PBH
$2.39B
$31.8M 1.73%
509,668
-30,225
-6% -$2.1M
ESTA icon
13
Establishment Labs
ESTA
$2.71B
$31.2M 1.7%
760,197
-77,510
-9% -$3.17M
ASND icon
14
Ascendis Pharma A/S
ASND
$16.6B
$29.2M 1.59%
147,090
-13,020
-8% -$2.43M
DOCS icon
15
Doximity
DOCS
$3.77B
$28.9M 1.58%
395,555
-35,852
-8% -$2.34M
XPO icon
16
XPO
XPO
$24.4B
$28.9M 1.58%
223,594
-20,359
-8% -$2.64M
ZD icon
17
Ziff Davis
ZD
$1.93B
$28.7M 1.56%
753,202
-78,900
-9% -$2.76M
WEX icon
18
WEX
WEX
$6.07B
$27.4M 1.49%
173,985
-15,959
-8% -$2.64M
FOLD
19
DELISTED
Amicus Therapeutics
FOLD
$27.1M 1.48%
3,434,717
+674,403
+24% +$4.8M
GTLS
20
DELISTED
Chart Industries
GTLS
$26.1M 1.42%
130,527
-11,854
-8% -$2.25M
TKO icon
21
TKO Group
TKO
$13.7B
$26.1M 1.42%
129,085
-130,162
-50% -$23.8M
SUPN icon
22
Supernus Pharmaceuticals
SUPN
$2.73B
$22.8M 1.24%
476,081
-48,566
-9% -$1.96M
KNSA icon
23
Kiniksa Pharmaceuticals
KNSA
$4.89B
$22.4M 1.22%
577,822
-60,411
-9% -$1.96M
SRAD icon
24
Sportradar
SRAD
$4.34B
$21.5M 1.17%
+799,217
New +$23.7M
EEFT icon
25
Euronet Worldwide
EEFT
$3.01B
$20.9M 1.14%
238,009
-74,309
-24% -$7.12M
1
2 3 4 5

Similar funds

WIM
WealthPlan Investment Management Omaha, Nebraska $1.79B AUM 17.59% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
JCM
Jacobi Capital Management Pittston, Pennsylvania $1.79B AUM 17.94% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return

Rice Hall James & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Rice Hall James & Associates held 261 positions worth $1.83B, down 1.2% from $1.86B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $201M in Q3 2025, closing 13 positions and reducing 199 holdings. Its most notable exit was Olo Inc, an estimated $4.38M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Sportradar worth $21.5M.

  • Rice Hall James & Associates's largest Q3 2025 buy was Sportradar: 799,217 shares worth $21.5M.
  • Rice Hall James & Associates added most to Shift4 in Q3 2025, an estimated $22.6M increase.
  • Rice Hall James & Associates's biggest Q3 2025 reduction was Verona Pharma, cutting an estimated $58.7M.
  • Rice Hall James & Associates fully exited Olo Inc in Q3 2025, selling an estimated $4.38M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.83B portfolio in Q3 2025.
  • Rice Hall James & Associates opened 14 new positions and closed 13 in Q3 2025.
  • Rice Hall James & Associates's portfolio value fell 1.2% quarter-over-quarter to $1.83B.

Based on Rice Hall James & Associates's 13F filing for Q3 2025, filed 16 Oct 2025.